AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2012
May 11, 2012
30016_dirs_2012-05-11_51c98aa6-c421-4cf6-9490-49333798bcd5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-05-09
Reporting Person: MCKEON BRIAN P (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-09 | Deferred Stock Unit | $ | A | 369 | Acquired | Common Stock (369) | Direct | |
| 2012-05-09 | Non-Qualified Stock Option (right to buy) | $88.09 | A | 3752 | Acquired | 2019-05-08 | Common Stock (3752) | Direct |
Footnotes
F1: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest 100% one year from the date of grant and are payable as common stock one year following the Director's resignation from the Board of Directors.
F2: Grant of options to buy shares of common stock that vest one year from the date of grant (05/09/2013).
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13